Micro-X Ltd
ASX:MX1
Relative Value
The Relative Value of one MX1 stock under the Base Case scenario is 0.29 AUD. Compared to the current market price of 0.09 AUD, Micro-X Ltd is Undervalued by 69%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
MX1 Competitors Multiples
Micro-X Ltd Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
AU |
Micro-X Ltd
ASX:MX1
|
46.6m AUD | 3.1 | -3.2 | -3.2 | -3.2 | ||
US |
Abbott Laboratories
NYSE:ABT
|
183.7B USD | 4.6 | 32.6 | 19.2 | 28.6 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
134B USD | 18.3 | 67.4 | 55.3 | 69.3 | ||
US |
Stryker Corp
NYSE:SYK
|
124.3B USD | 5.9 | 37 | 24 | 29.6 | ||
IE |
Medtronic PLC
NYSE:MDT
|
107.6B USD | 3.3 | 25.6 | 13.6 | 19.3 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
105.6B USD | 7.2 | 59.8 | 30.5 | 45 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
69.4B USD | 3.6 | 57 | 19 | 40.2 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
57.1B EUR | 2.6 | 37.6 | 18.1 | 30.6 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
51.2B USD | 8.3 | 36.2 | 26.3 | 28.5 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.4B CNY | 10.7 | 32.5 | 28.3 | 28.3 | ||
US |
Dexcom Inc
NASDAQ:DXCM
|
50.2B USD | 13.2 | 78.5 | 58.6 | 76.4 |